StockNews.com assumed coverage on shares of InfuSystem (NYSE:INFU – Get Rating) in a research report issued on Thursday. The brokerage set a “buy” rating on the stock.
InfuSystem Stock Performance
About InfuSystem
InfuSystem Holdings, Inc engages in the provision of healthcare services. It operates through the Integrated Therapy Services and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on providing electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics.
Further Reading
- Get a free copy of the StockNews.com research report on InfuSystem (INFU)
- 5 Best Bank ETFs to Buy Now
- How to Invest in Telehealth and Telemedicine Stocks
- Target’s Guidance Looms Over The MarketÂ
- Want Clean Energy? Siemens May Be Pointing To A Breakout
- Up Over 2,600% in 5 Years, Wall Street Still Calls Celsius a Buy
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
